Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
Lixte Biotechnology Holdings, Inc. (LIXT) had Current Liabilities of $1.33M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-2.56M |
|
-- |
|
-- |
|
$1.82M |
|
$-1.82M |
|
$-0.72M |
|
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
$-1.82M |
|
$-1.82M |
|
4.84M |
|
4.84M |
|
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$5.18M |
|
-- |
|
$7.56M |
|
$12.73M |
|
|
Current Liabilities |
$1.33M |
-- |
|
$0.44M |
|
$1.77M |
|
$9.23M |
|
$10.96M |
|
$10.96M |
|
8.79M |
|
| Cash Flow Statement Financials | |
$-3.07M |
|
$-3.17M |
|
$10.31M |
|
$1.04M |
|
$5.11M |
|
$4.07M |
|
$1.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-27.57% |
|
-23.21% |
|
-19.98% |
|
-23.21% |
|
$1.25 |
|
$-0.63 |
|
$-0.63 |
|